Detection & Management of Retinal Emboli in a County Diabetes Retinal Screening Programme an audit

Similar documents
Main Effect of Screening for Coronary Artery Disease Using CT

Trends in Prescribing of Drugs for Type 2 Diabetes in General Practice in England (Chart 1) Other intermediate and long-acting insulins

Cardiovascular Disease in Diabetes

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Cardiovascular Risk in Diabetes

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Listen to your heart: Good Cardiovascular Health for Life

Diabetes Complications

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

Perioperative Cardiac Evaluation

Medical Management of Ischemic Stroke: An Update. Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence

The author has no disclosures

Atherosclerosis of the aorta. Artur Evangelista

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

Long term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Renovascular Hypertension

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

The 50-year Quest to Replace Warfarin: Novel Anticoagulants Define a New Era. CCRN State of the Heart 2012 June 2, 2012

What is Vascular Surgery Worth to a Health Care System?

Catheter insertion of a new aortic valve to treat aortic stenosis

Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Cardiovascular risk assessment: Audit findings from a nurse clinic a quality improvement initiative

2016 International Stroke Conference Hot Topics Lori M. Massaro, MSN, CRNP Kari Moore, MSN, AGACNP-BC

The Economic Impact and Cost-Effectiveness of Glucose Monitoring

Duration of Dual Antiplatelet Therapy After Coronary Stenting

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

STROKE PREVENTION IN ATRIAL FIBRILLATION

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine

Making Sense of the New Statin guidelines. They are more than just lowering your cholesterol!

Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines

ALBERTA PROVINCIAL STROKE STRATEGY (APSS)

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

Table e-1: Description of the three participating centres Umeå, Sweden Dublin, Ireland Barcelona, Spain Population-based study with single

Diabetes, hypertension and a lot more `in the elderly` JORIS SCHAKEL INTERNIST- CLINICAL GERIATRICIAN JGSCHAKEL@SEHOS.CW

How To Know If Low Protein Diet Is Beneficial For Kidney Health

National Diabetes Inpatient Audit

Cardiovascular Effects of Drugs to Treat Diabetes

ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE

Vertebrobasilar Disease

Ultrasound in Vascular Surgery. Torbjørn Dahl

4. Does your PCT provide structured education programmes for people with type 2 diabetes?

Stroke Prevention in Primary Care

Jill Malcolm, Karen Moir

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators

Drug Treatment in Type 2 Diabetes with Hypertension

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

Stroke Care First week

FOR THE PREVENTION OF ATRIAL FIBRILLATION RELATED STROKE

None. Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management. 76 year old male LINGO 1/5/2015

Atrial Fibrillation An update on diagnosis and management

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications

Guidelines for Use of Clopidogrel (Plavix )

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

U.S. Food and Drug Administration

CARDIAC CARE. Giving you every advantage

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

Managing diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ)

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Lower extremity artery disease. Erich Minar Medical University Vienna

Cost-effectiveness analysis of TAVI compared to standard treatment of symptomatic aortic stenosis in patients at high surgical risk.

Absolute cardiovascular disease risk assessment

CARDIAC RISKS OF NON CARDIAC SURGERY

Pre-Operative Cardiac Evaluation Kalpana Jain, MD

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

ECG may be indicated for patients with cardiovascular risk factors

NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation

Yul D. Ejnes, MD, MACP Clinical Associate Professor of Medicine Warren Alpert Medical School of Brown University Chair-Emeritus, Board of Regents

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Chronic diseases in low and middle income countries: more research or more action? Shah Ebrahim London School of Hygiene & Tropical Medicine

How to Keep Your Surgeon Out of Trouble: Perioperative Medicine: Risk Stratification

DIABETES CARE. Advice. Blood Pressure. Cholesterol. Diabetes control. Eyes. Feet. Guardian Drugs

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus

Quantifying Life expectancy in people with Type 2 diabetes

RESULTS OF MEDICAL VERSUS SURGICAL TREATMENT OF RENOVASCULAR HYPERTENSION

Cilostazol versus Clopidogrel after Coronary Stenting

WEIGHT LOSS SURGERY. Pre-Clinic Conference Jennifer Kinley, MD 12/15/2010

ABOUT XARELTO CLINICAL STUDIES

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

How To Determine Pad

National Diabetes Audit and Report 1: Care Processes and Treatment Targets. Version 1.0 Published: 28 January 2016

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

Mohammad Reza Motamed MD 29, Seyed-Mohammad Fereshtehnejad 30, Nooshin Sadigh 2

Diabetic Nephropathy

Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE

Type 1 Diabetes ( Juvenile Diabetes)

The International Agenda for Stroke

National Medicines Information Centre

Transcription:

Detection & Management of Retinal Emboli in a County Diabetes Retinal Screening Programme an audit Prashant K Singh Specialist Registrar in Endocrinology, Diabetes & Internal Medicine The Royal Shrewsbury Hospital

Conclusion A systematic approach to evaluation of patients with retinal emboli (RAE) is another step in vascular risk management of patients with DM Moderate to severe carotid artery disease are a common finding amongst patients with RAE Limited information to recommend surgery Whether or not this approach affects long term outcomes remains to be established

Background Retinal arteriolar emboli (RAE) are detected in 1.3 1.4% of the adult population 1 Associated with an excess risk of all-cause and stroke related mortality. 2,3 May originate from atheromatous carotid arteries or degenerate cardiac valves Incidental detection during diabetic retinal screening allows risk management and surgical intervention where appropriate 1. BMES: Clin Exp Ophthal 2000; 2. BDES: Arch Ophthal 2003. 3. Wang: Stroke 2006

Process Images of incidentally discovered RAE are scrutinised by an experienced clinician (AFM) Letter sent to the primary care informing Implications of the findings Pharmacological preventative therapy Need for carotid doppler sonography (+/- surgical referral), where appropriate

Results Between January 2008 and August 2009, 16532 patients attended for retinal screen 66 patients identified with RAE (median age 72 years; range 45 90) 23 (38%) classified as cholesterol or plateletfibrin emboli. 15(23%) had calcific. Rest (39%) unclassified. 25 (42%) had carotid doppler studies

Results 13(23%) patients had a previous history of cerebrovascular disease. Further 19(30%) had a history of IHD. 6(9%) had both. 80% had antiplatelet/anticoagulant therapy (ALL patients with history of stroke AND all who had carotid dopplers)

Results Carotid Doppler Findings Degree of stenosis (N=25) Number (%) Severe Stenosis (N=8) 2 patients had endarterectomies (1 stroke post procedure) Mild (0 30%) Moderate (30 70%) Severe (>70%) 13 (52) 4 (16) 8 (32) 1 patient died 1 had bilateral occlusion (no further evaluation) 4 patients <75 years had no intervention (1 with history of CVA)

Discussion Our numbers are smaller than those in population prevalence studies incidental discovery number of fields 80% on antithrombotic treatment. 4 50% patients with a severe carotid artery stenosis did not have intervention (reasons unclear) 4. POPADAD: BMJ 2008

7-year incidence of cardiovascular events (%) CV risk in Type 2 diabetes approaches the risk in patients with a history of MI 50 40 30 20 10 0 No history of MI Type 2 diabetes Non-diabetic History of MI Haffner SM et al. N Engl J Med 1998; 339: 229 234.

Diabetes Interventions Steno 2 Trial Aggressive multifactorial target-driven interventions reduce CVD in high risk individuals by 50% Comparable (Alphabet) Strategy (developed in George Elliott Hospital showed comparable results). A B C D E F G

Diabetes Interventions Steno 2 Trial Aggressive multifactorial target-driven interventions reduce CVD in high risk individuals by 50% Comparable (Alphabet) Strategy (developed in George Elliott Hospital showed comparable results). Advice Blood pressure Cholesterol Diabetes control Eye screening Foot Screening Guardian drugs

Diabetes Interventions Steno 2 Trial Aggressive multifactorial target-driven interventions reduce CVD in high risk individuals by 50% Comparable (Alphabet) Strategy (developed in George Elliott Hospital showed comparable results). Advice Blood pressure Cholesterol Diabetes control Eye screening Foot Screening Guardian drugs e.g. Aspirin

Carotid Artery Stenosis (Asymptomatic Vs Symptomatic) Good evidence that CEA beneficial in symptomatic patients 1 Evidence of benefit in asymptomatic patients limited 2 Limited information for patients with DM? higher rates of peri-operative complications 3 Very little information for patients with RAE 1. Cochrane Review; 2. Cochrane review; 3. SMART

Current Practice All patients invited to diabetes centre for Clinical evaluation Education Investigation Follow up Follow up Audit loop

Conclusion A systematic approach to evaluation of patients with RAE is another step in vascular risk management of patients with DM Moderate to severe carotid artery disease are a common finding amongst patients with RAE Limited information to recommend surgery Whether or not this approach affects long term outcomes remains to be established